Navigation Links
Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
Date:2/26/2013

TOKYO, Feb. 27, 2013 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI) ) to the Japanese Ministry of Health, Labor and Welfare. Taiho Pharmaceutical is seeking approval of TAS-102 for the indication of unresectable, advanced, recurrent colorectal cancer.

The application for approval is based on the results of a Phase II clinical trial (Study 10040030) conducted at 20 facilities throughout Japan. It was a randomized, double-blind comparative study of TAS-102 and a placebo involving 172 patients with unresectable, advanced, recurrent colorectal cancer that was refractory to the standard chemotherapy of at least two or more regimens containing fluoropyrimidine, irinotecan, and oxaliplatin. The results indicated that the group administered TAS-102 had improved overall survival rates (median overall survival: 9.0 months vs. 6.6 months) and a significantly reduced risk of mortality (HR: 0.56, p=0.0011). The most frequently reported adverse drug reaction with a CTCAE grade of 3 or higher was neutropenia. Grade 3 or higher diarrhea, fatigue, nausea, and other adverse reactions were no more than 10%. Taiho Pharmaceutical is currently proceeding with a global Phase III clinical trial of TAS-102 in a similar colorectal cancer population (RECOURSE) with the ultimate goal of global registration and commercialization of the agent.

Taiho Pharmaceutical believes that TAS-102 will make a significant contribution to cancer patients and will continue its development efforts to broaden its use.

About TAS-102
TAS-102 is an antitumor agent composed of a combination of trifluorothymidine (FTD), a nucleoside that incorporates into DNA and inhibits a variety of gene
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
2. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
3. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
4. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
5. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
6. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
7. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
10. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
11. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... 25, 2015  With the introduction of Elekta,s new ... radiosurgery are now available for more patients with a ... generation stereotactic radiosurgery system for the brain, integrates advanced ... the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ... its rejection of the unsolicited offer from Mylan NV ... the outstanding shares of Perrigo for $60.00 per share ... ordinary Perrigo share (the "Offer").  The ... per share significantly undervalued the Company and its future ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices ... clients, took that commitment to a whole new level with ... it easier for existing and potential clients to contact the ... and added value to the firm’s services, #Dan covers Central ... has law offices. , “I knew the pound sign (#) ...
(Date:4/27/2015)... 27, 2015 Texas has saved $433 ... drug offenders to providing drug offenders with addiction treatment, ... on April 8th. Several states, including Massachusetts, are considering ... incarceration. Texas has formed community recovery programs to help ... The Council of State Governments WA, ID, NE, ...
(Date:4/27/2015)... 2015 Climate change predictions are largely ... the number of variables used and the availability of ... water researcher Gerald Pollack, PhD, and Climatologist L.DeWayne Cecil, ... Water® radio show, noted three potential weaknesses that could ... of these individuals dispute that Earth’s climate is changing. ...
(Date:4/27/2015)... Winscribe Professional for Windows Phones ... mobile speech productivity technology, which also includes applications ... , Winscribe has supported mobile dictation ... With the latest enhancement, Winscribe Professional for ... interface in the last ten years. The ...
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider ... with the addition of an account manager in Houston. ... a growing customer base, Curtis Rice, an experienced sales ... Account Manager. Curtis has been added to the team ... the Houston area and beyond. , Curtis ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 2Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 4Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2
... Bangalore, SUNNYVALE, Calif., Jan. 8 Accuray,Incorporated ... the field of radiosurgery,announced today that Healthcare Global ... for its new oncology center in,Bangalore, India. Upon ... first,CyberKnife System in India, expanding treatment access to ...
... N.J., Jan. 8 Jennifer J. Day, Senior Vice,President ... the,addition of Kenneth A. Sylvia as publisher of Current ... healthcare industry who brings to DHM,30 years of experience ... bases we serve," Day said. DHM is a subsidiary ...
... Affairs highlights large employer,s efforts to ... to treatment, PHILADELPHIA, Jan. 8 Removing ... to remain,on recommended therapies according to a new ... Health Affairs. The study, funded, in part,by GlaxoSmithKline ...
... Too Faced ... Cosmetics and FUZE Beverages, NEW YORK, Jan. 8 ... a lip gloss that keeps you both energized,and beautiful. Yes indeed ... lip gloss on the market to "fuse" beauty and fitness,benefits, this ...
... Centers and free coffee ... give blood, DETROIT, Jan. 8 In honor of ... Cross Donors,Employees and Volunteers in Michigan for two weeks in ... all donors,at any of the participating American Red Cross blood ...
... Medicaid spending slowed for first time since its inception ... The new Medicare prescription drug plan was largely responsible ... 2006, which was double the increase in spending from ... 2006, Medicare spending reached $401.3 billion, an increase from ...
Cached Medicine News:Health News:CyberKnife Radiosurgery Expands to India 2Health News:CyberKnife Radiosurgery Expands to India 3Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 2Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 3Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 4Health News:New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases 5Health News:NEW! Too Faced FUZE Slenderize Guilt Free Gloss 2Health News:Dunkin' Donuts Celebrates the New Year by Supplying Goodies to Michigan's American Red Cross 2Health News:Medicare Drug Plan Fuels Health-Care Spending 2Health News:Medicare Drug Plan Fuels Health-Care Spending 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... requires making decisions about insulin dosages and ... decisions are guided by data from blood ... by the patterns that can be seen ... when the data is presented in organized ...
... Pumped Green Photocoagulator - Portable and rugged ... outpatient clinic, and operating room. Built to ... in the most demanding environments, the Novus ... A full line of accessories for ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: